Argus Research Maintains Buy on Albemarle, Raises Price Target to $230

Benzinga Newsdesk www.benzinga.com Positive 85.6%

Neg 0% Neu 0% Pos 85.6%

Argus Research analyst Bill Selesky maintains Albemarle (NYSE:ALB) with a Buy and raises the price target from $185 to $230.